Odyssey Health, Inc. is a unique, medical device technology holding company, publicly traded on the OTC under the ticker ODYY. We develop and acquire life saving medical products with a technological and clinical advantage. Odyssey Health, inc. plans to develop a neurosteroid (PRV-002) for concussion treatment in humans. PRV-002 is a fully synthetic non-naturally occurring neurosteroid administered through the nasal cavity. PR...
Odyssey Health, Inc. is a unique, medical device technology holding company, publicly traded on the OTC under the ticker ODYY. We develop and acquire life saving medical products with a technological and clinical advantage. Odyssey Health, inc. plans to develop a neurosteroid (PRV-002) for concussion treatment in humans. PRV-002 is a fully synthetic non-naturally occurring neurosteroid administered through the nasal cavity. PRV-002 carries with it equivalent, if not superior, neuroprotective effects compared to related neurosteroids.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.